Live feed16:15:07·251dINSIDERFilingvia QuantisnowCHIEF SCIENTIFIC OFFICER Nuss John sold $97,840 worth of shares (12,675 units at $7.72) and converted options into 34,930 shares, increasing direct ownership by 5% to 489,481 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.VTYX· Ventyx Biosciences Inc.Health CareOriginal source